APO Research
Talk to an analyst

APO RESEARCH · REPORT

Etodolac

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Etodolac Market Analysis and Forecast 2026-2032

23 December 2025196 pages

Choose your research edition.

Industry ResearchEtodolac Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Etodolac Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Etodolac Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Etodolac Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Etodolac Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Etodolac market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Etodolac is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Etodolac is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Etodolac is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Etodolac is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Etodolac include Teva, Taro Pharmaceuticals, Physicians Total Care, PD-Rx Pharmaceuticals, Nucare Pharmaceuticals, Genpharm Ulc, Eon Labs, Blenheim Pharmacal and Apotex, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Etodolac, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Etodolac, also provides the sales of main regions and countries. Of the upcoming market potential for Etodolac, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Etodolac sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Etodolac market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Etodolac sales, projected growth trends, production technology, application and end-user industry.

Etodolac Segment by Company

Teva

Taro Pharmaceuticals

Physicians Total Care

PD-Rx Pharmaceuticals

Nucare Pharmaceuticals

Genpharm Ulc

Eon Labs

Blenheim Pharmacal

Apotex

Amneal Pharmaceuticals

Actavis Elizabeth

Etodolac Segment by Type

Tablets

Capsules

Etodolac Segment by Application

Mild to Moderate Pain

Rheumatoid Arthritis

Osteoarthritis

Others

Etodolac Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Etodolac market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Etodolac and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Etodolac.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Etodolac in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Etodolac manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Etodolac sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Etodolac Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Tablets Major Manufacturers Table 3. Capsules Major Manufacturers Table 4. Global Etodolac Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Mild to Moderate Pain Major Manufacturers Table 6. Rheumatoid Arthritis Major Manufacturers Table 7. Osteoarthritis Major Manufacturers Table 8. Others Major Manufacturers Table 9. Etodolac Industry Trends Table 10. Etodolac Industry Drivers Table 11. Etodolac Industry Opportunities and Challenges Table 12. Etodolac Industry Restraints Table 13. Global Etodolac Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Etodolac Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Etodolac Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Etodolac Revenue Market Share by Region (2021-2026) Table 17. Global Etodolac Revenue Market Share by Region (2027-2032) Table 18. Global Etodolac Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k pcs) Table 19. Global Etodolac Sales by Region (2021-2026) & (k pcs) Table 20. Global Etodolac Sales by Region (2027-2032) & (k pcs) Table 21. Global Etodolac Sales Market Share by Region (2021-2026) Table 22. Global Etodolac Sales Market Share by Region (2027-2032) Table 23. Global Etodolac Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Etodolac Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Etodolac Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Etodolac Sales Market Share by Manufacturers (2021-2026) Table 27. Global Etodolac Sales Price (US$/pcs) of Manufacturers (2021-2026) Table 28. Global Etodolac Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Etodolac Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Etodolac Manufacturers, Product Type & Application Table 31. Global Etodolac Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Etodolac by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Etodolac Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Etodolac Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Etodolac Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Etodolac Revenue Market Share by Type (2021-2026) Table 38. Global Etodolac Revenue Market Share by Type (2027-2032) Table 39. Global Etodolac Sales by Type 2021 VS 2025 VS 2032 (k pcs) Table 40. Global Etodolac Sales by Type (2021-2026) & (k pcs) Table 41. Global Etodolac Sales by Type (2027-2032) & (k pcs) Table 42. Global Etodolac Sales Market Share by Type (2021-2026) Table 43. Global Etodolac Sales Market Share by Type (2027-2032) Table 44. Global Etodolac Price by Type (2021-2026) & (US$/pcs) Table 45. Global Etodolac Price by Type (2027-2032) & (US$/pcs) Table 46. Global Etodolac Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Etodolac Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Etodolac Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Etodolac Revenue Market Share by Application (2021-2026) Table 50. Global Etodolac Revenue Market Share by Application (2027-2032) Table 51. Global Etodolac Sales by Application 2021 VS 2025 VS 2032 (k pcs) Table 52. Global Etodolac Sales by Application (2021-2026) & (k pcs) Table 53. Global Etodolac Sales by Application (2027-2032) & (k pcs) Table 54. Global Etodolac Sales Market Share by Application (2021-2026) Table 55. Global Etodolac Sales Market Share by Application (2027-2032) Table 56. Global Etodolac Price by Application (2021-2026) & (US$/pcs) Table 57. Global Etodolac Price by Application (2027-2032) & (US$/pcs) Table 58. Teva Company Information Table 59. Teva Business Overview Table 60. Teva Etodolac Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 61. Teva Etodolac Product Portfolio Table 62. Teva Recent Development Table 63. Taro Pharmaceuticals Company Information Table 64. Taro Pharmaceuticals Business Overview Table 65. Taro Pharmaceuticals Etodolac Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 66. Taro Pharmaceuticals Etodolac Product Portfolio Table 67. Taro Pharmaceuticals Recent Development Table 68. Physicians Total Care Company Information Table 69. Physicians Total Care Business Overview Table 70. Physicians Total Care Etodolac Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 71. Physicians Total Care Etodolac Product Portfolio Table 72. Physicians Total Care Recent Development Table 73. PD-Rx Pharmaceuticals Company Information Table 74. PD-Rx Pharmaceuticals Business Overview Table 75. PD-Rx Pharmaceuticals Etodolac Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 76. PD-Rx Pharmaceuticals Etodolac Product Portfolio Table 77. PD-Rx Pharmaceuticals Recent Development Table 78. Nucare Pharmaceuticals Company Information Table 79. Nucare Pharmaceuticals Business Overview Table 80. Nucare Pharmaceuticals Etodolac Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 81. Nucare Pharmaceuticals Etodolac Product Portfolio Table 82. Nucare Pharmaceuticals Recent Development Table 83. Genpharm Ulc Company Information Table 84. Genpharm Ulc Business Overview Table 85. Genpharm Ulc Etodolac Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 86. Genpharm Ulc Etodolac Product Portfolio Table 87. Genpharm Ulc Recent Development Table 88. Eon Labs Company Information Table 89. Eon Labs Business Overview Table 90. Eon Labs Etodolac Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 91. Eon Labs Etodolac Product Portfolio Table 92. Eon Labs Recent Development Table 93. Blenheim Pharmacal Company Information Table 94. Blenheim Pharmacal Business Overview Table 95. Blenheim Pharmacal Etodolac Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 96. Blenheim Pharmacal Etodolac Product Portfolio Table 97. Blenheim Pharmacal Recent Development Table 98. Apotex Company Information Table 99. Apotex Business Overview Table 100. Apotex Etodolac Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 101. Apotex Etodolac Product Portfolio Table 102. Apotex Recent Development Table 103. Amneal Pharmaceuticals Company Information Table 104. Amneal Pharmaceuticals Business Overview Table 105. Amneal Pharmaceuticals Etodolac Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 106. Amneal Pharmaceuticals Etodolac Product Portfolio Table 107. Amneal Pharmaceuticals Recent Development Table 108. Actavis Elizabeth Company Information Table 109. Actavis Elizabeth Business Overview Table 110. Actavis Elizabeth Etodolac Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 111. Actavis Elizabeth Etodolac Product Portfolio Table 112. Actavis Elizabeth Recent Development Table 113. North America Etodolac Revenue by Type (2021-2026) & (US$ Million) Table 114. North America Etodolac Revenue by Type (2027-2032) & (US$ Million) Table 115. North America Etodolac Sales by Type (2021-2026) & (k pcs) Table 116. North America Etodolac Sales by Type (2027-2032) & (k pcs) Table 117. North America Etodolac Sales Price by Type (2021-2026) & (US$/pcs) Table 118. North America Etodolac Sales Price by Type (2027-2032) & (US$/pcs) Table 119. North America Etodolac Revenue by Application (2021-2026) & (US$ Million) Table 120. North America Etodolac Revenue by Application (2027-2032) & (US$ Million) Table 121. North America Etodolac Sales by Application (2021-2026) & (k pcs) Table 122. North America Etodolac Sales by Application (2027-2032) & (k pcs) Table 123. North America Etodolac Sales Price by Application (2021-2026) & (US$/pcs) Table 124. North America Etodolac Sales Price by Application (2027-2032) & (US$/pcs) Table 125. North America Etodolac Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 126. North America Etodolac Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 127. North America Etodolac Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 128. North America Etodolac Sales by Country (2021 VS 2025 VS 2032) & (k pcs) Table 129. North America Etodolac Sales by Country (2021-2026) & (k pcs) Table 130. North America Etodolac Sales by Country (2027-2032) & (k pcs) Table 131. North America Etodolac Sales Price by Country (2021-2026) & (US$/pcs) Table 132. North America Etodolac Sales Price by Country (2027-2032) & (US$/pcs) Table 133. United States Etodolac Revenue (2021-2032) & (US$ Million) Table 134. Canada Etodolac Revenue (2021-2032) & (US$ Million) Table 135. Mexico Etodolac Revenue (2021-2032) & (US$ Million) Table 136. Europe Etodolac Revenue by Type (2021-2026) & (US$ Million) Table 137. Europe Etodolac Revenue by Type (2027-2032) & (US$ Million) Table 138. Europe Etodolac Sales by Type (2021-2026) & (k pcs) Table 139. Europe Etodolac Sales by Type (2027-2032) & (k pcs) Table 140. Europe Etodolac Sales Price by Type (2021-2026) & (US$/pcs) Table 141. Europe Etodolac Sales Price by Type (2027-2032) & (US$/pcs) Table 142. Europe Etodolac Revenue by Application (2021-2026) & (US$ Million) Table 143. Europe Etodolac Revenue by Application (2027-2032) & (US$ Million) Table 144. Europe Etodolac Sales by Application (2021-2026) & (k pcs) Table 145. Europe Etodolac Sales by Application (2027-2032) & (k pcs) Table 146. Europe Etodolac Sales Price by Application (2021-2026) & (US$/pcs) Table 147. Europe Etodolac Sales Price by Application (2027-2032) & (US$/pcs) Table 148. Europe Etodolac Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 149. Europe Etodolac Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 150. Europe Etodolac Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 151. Europe Etodolac Sales by Country (2021 VS 2025 VS 2032) & (k pcs) Table 152. Europe Etodolac Sales by Country (2021-2026) & (k pcs) Table 153. Europe Etodolac Sales by Country (2027-2032) & (k pcs) Table 154. Europe Etodolac Sales Price by Country (2021-2026) & (US$/pcs) Table 155. Europe Etodolac Sales Price by Country (2027-2032) & (US$/pcs) Table 156. Germany Etodolac Revenue (2021-2032) & (US$ Million) Table 157. France Etodolac Revenue (2021-2032) & (US$ Million) Table 158. U.K. Etodolac Revenue (2021-2032) & (US$ Million) Table 159. Italy Etodolac Revenue (2021-2032) & (US$ Million) Table 160. Russia Etodolac Revenue (2021-2032) & (US$ Million) Table 161. Spain Etodolac Revenue (2021-2032) & (US$ Million) Table 162. Netherlands Etodolac Revenue (2021-2032) & (US$ Million) Table 163. Switzerland Etodolac Revenue (2021-2032) & (US$ Million) Table 164. Sweden Etodolac Revenue (2021-2032) & (US$ Million) Table 165. Poland Etodolac Revenue (2021-2032) & (US$ Million) Table 166. China Etodolac Revenue by Type (2021-2026) & (US$ Million) Table 167. China Etodolac Revenue by Type (2027-2032) & (US$ Million) Table 168. China Etodolac Sales by Type (2021-2026) & (k pcs) Table 169. China Etodolac Sales by Type (2027-2032) & (k pcs) Table 170. China Etodolac Sales Price by Type (2021-2026) & (US$/pcs) Table 171. China Etodolac Sales Price by Type (2027-2032) & (US$/pcs) Table 172. China Etodolac Revenue by Application (2021-2026) & (US$ Million) Table 173. China Etodolac Revenue by Application (2027-2032) & (US$ Million) Table 174. China Etodolac Sales by Application (2021-2026) & (k pcs) Table 175. China Etodolac Sales by Application (2027-2032) & (k pcs) Table 176. China Etodolac Sales Price by Application (2021-2026) & (US$/pcs) Table 177. China Etodolac Sales Price by Application (2027-2032) & (US$/pcs) Table 178. Asia Etodolac Revenue by Type (2021-2026) & (US$ Million) Table 179. Asia Etodolac Revenue by Type (2027-2032) & (US$ Million) Table 180. Asia Etodolac Sales by Type (2021-2026) & (k pcs) Table 181. Asia Etodolac Sales by Type (2027-2032) & (k pcs) Table 182. Asia Etodolac Sales Price by Type (2021-2026) & (US$/pcs) Table 183. Asia Etodolac Sales Price by Type (2027-2032) & (US$/pcs) Table 184. Asia Etodolac Revenue by Application (2021-2026) & (US$ Million) Table 185. Asia Etodolac Revenue by Application (2027-2032) & (US$ Million) Table 186. Asia Etodolac Sales by Application (2021-2026) & (k pcs) Table 187. Asia Etodolac Sales by Application (2027-2032) & (k pcs) Table 188. Asia Etodolac Sales Price by Application (2021-2026) & (US$/pcs) Table 189. Asia Etodolac Sales Price by Application (2027-2032) & (US$/pcs) Table 190. Asia Etodolac Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 191. Asia Etodolac Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 192. Asia Etodolac Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 193. Asia Etodolac Sales by Country (2021 VS 2025 VS 2032) & (k pcs) Table 194. Asia Etodolac Sales by Country (2021-2026) & (k pcs) Table 195. Asia Etodolac Sales by Country (2027-2032) & (k pcs) Table 196. Asia Etodolac Sales Price by Country (2021-2026) & (US$/pcs) Table 197. Asia Etodolac Sales Price by Country (2027-2032) & (US$/pcs) Table 198. Japan Etodolac Revenue (2021-2032) & (US$ Million) Table 199. South Korea Etodolac Revenue (2021-2032) & (US$ Million) Table 200. India Etodolac Revenue (2021-2032) & (US$ Million) Table 201. Australia Etodolac Revenue (2021-2032) & (US$ Million) Table 202. Taiwan Etodolac Revenue (2021-2032) & (US$ Million) Table 203. Southeast Asia Etodolac Revenue (2021-2032) & (US$ Million) Table 204. SAMEA Etodolac Revenue by Type (2021-2026) & (US$ Million) Table 205. SAMEA Etodolac Revenue by Type (2027-2032) & (US$ Million) Table 206. SAMEA Etodolac Sales by Type (2021-2026) & (k pcs) Table 207. SAMEA Etodolac Sales by Type (2027-2032) & (k pcs) Table 208. SAMEA Etodolac Sales Price by Type (2021-2026) & (US$/pcs) Table 209. SAMEA Etodolac Sales Price by Type (2027-2032) & (US$/pcs) Table 210. SAMEA Etodolac Revenue by Application (2021-2026) & (US$ Million) Table 211. SAMEA Etodolac Revenue by Application (2027-2032) & (US$ Million) Table 212. SAMEA Etodolac Sales by Application (2021-2026) & (k pcs) Table 213. SAMEA Etodolac Sales by Application (2027-2032) & (k pcs) Table 214. SAMEA Etodolac Sales Price by Application (2021-2026) & (US$/pcs) Table 215. SAMEA Etodolac Sales Price by Application (2027-2032) & (US$/pcs) Table 216. SAMEA Etodolac Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 217. SAMEA Etodolac Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 218. SAMEA Etodolac Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 219. SAMEA Etodolac Sales by Country (2021 VS 2025 VS 2032) & (k pcs) Table 220. SAMEA Etodolac Sales by Country (2021-2026) & (k pcs) Table 221. SAMEA Etodolac Sales by Country (2027-2032) & (k pcs) Table 222. SAMEA Etodolac Sales Price by Country (2021-2026) & (US$/pcs) Table 223. SAMEA Etodolac Sales Price by Country (2027-2032) & (US$/pcs) Table 224. Brazil Etodolac Revenue (2021-2032) & (US$ Million) Table 225. Argentina Etodolac Revenue (2021-2032) & (US$ Million) Table 226. Chile Etodolac Revenue (2021-2032) & (US$ Million) Table 227. Colombia Etodolac Revenue (2021-2032) & (US$ Million) Table 228. Peru Etodolac Revenue (2021-2032) & (US$ Million) Table 229. Saudi Arabia Etodolac Revenue (2021-2032) & (US$ Million) Table 230. Israel Etodolac Revenue (2021-2032) & (US$ Million) Table 231. UAE Etodolac Revenue (2021-2032) & (US$ Million) Table 232. Turkey Etodolac Revenue (2021-2032) & (US$ Million) Table 233. Iran Etodolac Revenue (2021-2032) & (US$ Million) Table 234. Egypt Etodolac Revenue (2021-2032) & (US$ Million) Table 235. Key Raw Materials Table 236. Raw Materials Key Suppliers Table 237. Etodolac Distributors List Table 238. Etodolac Customers List Table 239. Research Programs/Design for This Report Table 240. Authors List of This Report Table 241. Secondary Sources Table 242. Primary Sources List of Figures Figure 1. Etodolac Image Figure 2. Global Etodolac Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Etodolac Market Size Share 2021 VS 2025 VS 2032 Figure 4. Tablets Image Figure 5. Capsules Image Figure 6. Global Etodolac Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Etodolac Market Size Share 2021 VS 2025 VS 2032 Figure 8. Mild to Moderate Pain Image Figure 9. Rheumatoid Arthritis Image Figure 10. Osteoarthritis Image Figure 11. Others Image Figure 12. Global Etodolac Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Etodolac Revenue (2021-2032) & (US$ Million) Figure 14. Global Etodolac Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Etodolac Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Etodolac Revenue Market Share by Region (2021-2032) Figure 17. Global Etodolac Sales (2021-2032) & (k pcs) Figure 18. Global Etodolac Sales by Region: 2021 VS 2025 VS 2032 (k pcs) Figure 19. Global Etodolac Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Etodolac Sales YoY (2021-2032) & (k pcs) Figure 21. Europe Etodolac Sales YoY (2021-2032) & (k pcs) Figure 22. China Etodolac Sales YoY (2021-2032) & (k pcs) Figure 23. Asia (Excluding China) Etodolac Sales YoY (2021-2032) & (k pcs) Figure 24. South America, Middle East and Africa Etodolac Sales YoY (2021-2032) & (k pcs) Figure 25. Global Etodolac Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Etodolac Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Etodolac Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Etodolac Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Etodolac Revenue Market Share by Type (2021-2032) Figure 31. Global Etodolac Sales by Type (2021 VS 2025 VS 2032) & (k pcs) Figure 32. Global Etodolac Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Etodolac Sales Market Share by Type (2021-2032) Figure 34. Global Etodolac Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Etodolac Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Etodolac Revenue Market Share by Application (2021-2032) Figure 37. Global Etodolac Sales by Application (2021 VS 2025 VS 2032) & (k pcs) Figure 38. Global Etodolac Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Etodolac Sales Market Share by Application (2021-2032) Figure 40. North America Etodolac Revenue Share by Type (2021-2032) Figure 41. North America Etodolac Sales Share by Type (2021-2032) Figure 42. North America Etodolac Revenue Share by Application (2021-2032) Figure 43. North America Etodolac Sales Share by Application (2021-2032) Figure 44. North America Etodolac Revenue Share by Country (2021-2032) Figure 45. North America Etodolac Sales Share by Country (2021-2032) Figure 46. Europe Etodolac Revenue Share by Type (2021-2032) Figure 47. Europe Etodolac Sales Share by Type (2021-2032) Figure 48. Europe Etodolac Revenue Share by Application (2021-2032) Figure 49. Europe Etodolac Sales Share by Application (2021-2032) Figure 50. Europe Etodolac Revenue Share by Country (2021-2032) Figure 51. Europe Etodolac Sales Share by Country (2021-2032) Figure 52. China Etodolac Revenue Share by Type (2021-2032) Figure 53. China Etodolac Sales Share by Type (2021-2032) Figure 54. China Etodolac Revenue Share by Application (2021-2032) Figure 55. China Etodolac Sales Share by Application (2021-2032) Figure 56. Asia Etodolac Revenue Share by Type (2021-2032) Figure 57. Asia Etodolac Sales Share by Type (2021-2032) Figure 58. Asia Etodolac Revenue Share by Application (2021-2032) Figure 59. Asia Etodolac Sales Share by Application (2021-2032) Figure 60. Asia Etodolac Revenue Share by Country (2021-2032) Figure 61. Asia Etodolac Sales Share by Country (2021-2032) Figure 62. SAMEA Etodolac Revenue Share by Type (2021-2032) Figure 63. SAMEA Etodolac Sales Share by Type (2021-2032) Figure 64. SAMEA Etodolac Revenue Share by Application (2021-2032) Figure 65. SAMEA Etodolac Sales Share by Application (2021-2032) Figure 66. SAMEA Etodolac Revenue Share by Country (2021-2032) Figure 67. SAMEA Etodolac Sales Share by Country (2021-2032) Figure 68. Etodolac Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Etodolac Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Tablets
  • Capsules
Applications
  • Mild to Moderate Pain
  • Rheumatoid Arthritis
  • Osteoarthritis
  • Others
Companies covered
  • Teva
  • Taro Pharmaceuticals
  • Physicians Total Care
  • PD-Rx Pharmaceuticals
  • Nucare Pharmaceuticals
  • Genpharm Ulc
  • Eon Labs
  • Blenheim Pharmacal
  • Apotex
  • Amneal Pharmaceuticals
  • Actavis Elizabeth

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Etodolac Market by Type
  3. 1.2.1 Global Etodolac Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Tablets
  5. 1.2.3 Capsules
  6. 1.3 Etodolac Market by Application
  7. 1.3.1 Global Etodolac Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Mild to Moderate Pain
  9. 1.3.3 Rheumatoid Arthritis
  10. 1.3.4 Osteoarthritis
  11. 1.3.5 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Etodolac Market Dynamics
  1. 2.1 Etodolac Industry Trends
  2. 2.2 Etodolac Industry Drivers
  3. 2.3 Etodolac Industry Opportunities and Challenges
  4. 2.4 Etodolac Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Etodolac Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Etodolac Revenue by Region
  3. 3.2.1 Global Etodolac Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Etodolac Revenue by Region (2021-2026)
  5. 3.2.3 Global Etodolac Revenue by Region (2027-2032)
  6. 3.2.4 Global Etodolac Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Etodolac Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Etodolac Sales by Region
  9. 3.4.1 Global Etodolac Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Etodolac Sales by Region (2021-2026)
  11. 3.4.3 Global Etodolac Sales by Region (2027-2032)
  12. 3.4.4 Global Etodolac Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Etodolac Revenue by Manufacturers
  2. 4.1.1 Global Etodolac Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Etodolac Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Etodolac Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Etodolac Sales by Manufacturers
  6. 4.2.1 Global Etodolac Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Etodolac Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Etodolac Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Etodolac Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Etodolac Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Etodolac Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Etodolac Manufacturers, Product Type & Application
  13. 4.7 Global Etodolac Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Etodolac Market CR5 and HHI
  16. 4.8.2 2025 Etodolac Tier 1, Tier 2, and Tier 3
5 Etodolac Market by Type
  1. 5.1 Global Etodolac Revenue by Type
  2. 5.1.1 Global Etodolac Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Etodolac Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Etodolac Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Etodolac Sales by Type
  6. 5.2.1 Global Etodolac Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Etodolac Sales by Type (2021-2032) & (k pcs)
  8. 5.2.3 Global Etodolac Sales Market Share by Type (2021-2032)
  9. 5.3 Global Etodolac Price by Type
6 Etodolac Market by Application
  1. 6.1 Global Etodolac Revenue by Application
  2. 6.1.1 Global Etodolac Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Etodolac Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Etodolac Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Etodolac Sales by Application
  6. 6.2.1 Global Etodolac Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Etodolac Sales by Application (2021-2032) & (k pcs)
  8. 6.2.3 Global Etodolac Sales Market Share by Application (2021-2032)
  9. 6.3 Global Etodolac Price by Application
7 Company Profiles
  1. 7.1 Teva
  2. 7.1.1 Teva Company Information
  3. 7.1.2 Teva Business Overview
  4. 7.1.3 Teva Etodolac Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Teva Etodolac Product Portfolio
  6. 7.1.5 Teva Recent Developments
  7. 7.2 Taro Pharmaceuticals
  8. 7.2.1 Taro Pharmaceuticals Company Information
  9. 7.2.2 Taro Pharmaceuticals Business Overview
  10. 7.2.3 Taro Pharmaceuticals Etodolac Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Taro Pharmaceuticals Etodolac Product Portfolio
  12. 7.2.5 Taro Pharmaceuticals Recent Developments
  13. 7.3 Physicians Total Care
  14. 7.3.1 Physicians Total Care Company Information
  15. 7.3.2 Physicians Total Care Business Overview
  16. 7.3.3 Physicians Total Care Etodolac Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Physicians Total Care Etodolac Product Portfolio
  18. 7.3.5 Physicians Total Care Recent Developments
  19. 7.4 PD-Rx Pharmaceuticals
  20. 7.4.1 PD-Rx Pharmaceuticals Company Information
  21. 7.4.2 PD-Rx Pharmaceuticals Business Overview
  22. 7.4.3 PD-Rx Pharmaceuticals Etodolac Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 PD-Rx Pharmaceuticals Etodolac Product Portfolio
  24. 7.4.5 PD-Rx Pharmaceuticals Recent Developments
  25. 7.5 Nucare Pharmaceuticals
  26. 7.5.1 Nucare Pharmaceuticals Company Information
  27. 7.5.2 Nucare Pharmaceuticals Business Overview
  28. 7.5.3 Nucare Pharmaceuticals Etodolac Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Nucare Pharmaceuticals Etodolac Product Portfolio
  30. 7.5.5 Nucare Pharmaceuticals Recent Developments
  31. 7.6 Genpharm Ulc
  32. 7.6.1 Genpharm Ulc Company Information
  33. 7.6.2 Genpharm Ulc Business Overview
  34. 7.6.3 Genpharm Ulc Etodolac Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Genpharm Ulc Etodolac Product Portfolio
  36. 7.6.5 Genpharm Ulc Recent Developments
  37. 7.7 Eon Labs
  38. 7.7.1 Eon Labs Company Information
  39. 7.7.2 Eon Labs Business Overview
  40. 7.7.3 Eon Labs Etodolac Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Eon Labs Etodolac Product Portfolio
  42. 7.7.5 Eon Labs Recent Developments
  43. 7.8 Blenheim Pharmacal
  44. 7.8.1 Blenheim Pharmacal Company Information
  45. 7.8.2 Blenheim Pharmacal Business Overview
  46. 7.8.3 Blenheim Pharmacal Etodolac Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Blenheim Pharmacal Etodolac Product Portfolio
  48. 7.8.5 Blenheim Pharmacal Recent Developments
  49. 7.9 Apotex
  50. 7.9.1 Apotex Company Information
  51. 7.9.2 Apotex Business Overview
  52. 7.9.3 Apotex Etodolac Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Apotex Etodolac Product Portfolio
  54. 7.9.5 Apotex Recent Developments
  55. 7.10 Amneal Pharmaceuticals
  56. 7.10.1 Amneal Pharmaceuticals Company Information
  57. 7.10.2 Amneal Pharmaceuticals Business Overview
  58. 7.10.3 Amneal Pharmaceuticals Etodolac Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Amneal Pharmaceuticals Etodolac Product Portfolio
  60. 7.10.5 Amneal Pharmaceuticals Recent Developments
  61. 7.11 Actavis Elizabeth
  62. 7.11.1 Actavis Elizabeth Company Information
  63. 7.11.2 Actavis Elizabeth Business Overview
  64. 7.11.3 Actavis Elizabeth Etodolac Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Actavis Elizabeth Etodolac Product Portfolio
  66. 7.11.5 Actavis Elizabeth Recent Developments
8 North America
  1. 8.1 North America Etodolac Market Size by Type
  2. 8.1.1 North America Etodolac Revenue by Type (2021-2032)
  3. 8.1.2 North America Etodolac Sales by Type (2021-2032)
  4. 8.1.3 North America Etodolac Price by Type (2021-2032)
  5. 8.2 North America Etodolac Market Size by Application
  6. 8.2.1 North America Etodolac Revenue by Application (2021-2032)
  7. 8.2.2 North America Etodolac Sales by Application (2021-2032)
  8. 8.2.3 North America Etodolac Price by Application (2021-2032)
  9. 8.3 North America Etodolac Market Size by Country
  10. 8.3.1 North America Etodolac Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Etodolac Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Etodolac Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Etodolac Market Size by Type
  2. 9.1.1 Europe Etodolac Revenue by Type (2021-2032)
  3. 9.1.2 Europe Etodolac Sales by Type (2021-2032)
  4. 9.1.3 Europe Etodolac Price by Type (2021-2032)
  5. 9.2 Europe Etodolac Market Size by Application
  6. 9.2.1 Europe Etodolac Revenue by Application (2021-2032)
  7. 9.2.2 Europe Etodolac Sales by Application (2021-2032)
  8. 9.2.3 Europe Etodolac Price by Application (2021-2032)
  9. 9.3 Europe Etodolac Market Size by Country
  10. 9.3.1 Europe Etodolac Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Etodolac Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Etodolac Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Etodolac Market Size by Type
  2. 10.1.1 China Etodolac Revenue by Type (2021-2032)
  3. 10.1.2 China Etodolac Sales by Type (2021-2032)
  4. 10.1.3 China Etodolac Price by Type (2021-2032)
  5. 10.2 China Etodolac Market Size by Application
  6. 10.2.1 China Etodolac Revenue by Application (2021-2032)
  7. 10.2.2 China Etodolac Sales by Application (2021-2032)
  8. 10.2.3 China Etodolac Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Etodolac Market Size by Type
  2. 11.1.1 Asia Etodolac Revenue by Type (2021-2032)
  3. 11.1.2 Asia Etodolac Sales by Type (2021-2032)
  4. 11.1.3 Asia Etodolac Price by Type (2021-2032)
  5. 11.2 Asia Etodolac Market Size by Application
  6. 11.2.1 Asia Etodolac Revenue by Application (2021-2032)
  7. 11.2.2 Asia Etodolac Sales by Application (2021-2032)
  8. 11.2.3 Asia Etodolac Price by Application (2021-2032)
  9. 11.3 Asia Etodolac Market Size by Country
  10. 11.3.1 Asia Etodolac Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Etodolac Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Etodolac Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Etodolac Market Size by Type
  2. 12.1.1 SAMEA Etodolac Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Etodolac Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Etodolac Price by Type (2021-2032)
  5. 12.2 SAMEA Etodolac Market Size by Application
  6. 12.2.1 SAMEA Etodolac Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Etodolac Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Etodolac Price by Application (2021-2032)
  9. 12.3 SAMEA Etodolac Market Size by Country
  10. 12.3.1 SAMEA Etodolac Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Etodolac Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Etodolac Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Etodolac Value Chain Analysis
  2. 13.1.1 Etodolac Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Etodolac Production Mode & Process
  6. 13.2 Etodolac Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Etodolac Distributors
  9. 13.2.3 Etodolac Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst